Aktin Pharmaceuticals

Aktin Pharmaceuticals is a private biotechnology company based in Piscataway, New Jersey, focused on the discovery and development of novel small molecule therapeutics for oncology and infectious diseases. The company leverages its deep expertise in medicinal chemistry and structure-based drug design to target critical biological pathways, including the kinesin spindle protein (KSP) for cancer treatment. Aktin has received significant research funding through the Small Business Innovation Research (SBIR) program from the National Institutes of Health (NIH) to advance its pipeline. Its lead programs, such as AK-106 and AK-110, are designed to address high unmet medical needs in solid tumors and biodefense-related infections. The company is led by industry veterans with extensive experience in pharmaceutical R&D from major institutions and corporations.